What is it?
This term functions as a classification under statutory right and contract clause type, governing the nature of goods being exchanged or regulated by government mandates.
Quick answer
A drug usually means any substance that alters bodily structure or function. In contracts, its classification dictates regulatory compliance risk. Before signing, check if the contract specifies FDA approval status or DEA schedule.
Definitions
Legal Definition
A drug is any substance that affects the structure or function of the body, often triggering legal obligations under various statutes. When a contract specifies certain drugs, it establishes whether parties are agreeing to deliver controlled substances or regulated pharmaceuticals. Courts pay close attention to whether the drug falls under FDA classification versus DEA scheduling.
Plain-English Translation
A drug is like a hall pass for your body; when you use it, it lets you do something different, like run faster than usual. If you promise to give someone that specific pass, you are bound to hand it over.
Contract relevance
Misidentifying the drug can cause a breach of contract claim, voiding the agreement entirely if the substance is fundamentally different from what was described. The seller bears the primary risk regarding accurate description.
Document context
| Document type | Section | Why it matters |
|---|---|---|
| Supply Agreement | Definitions Section | To determine delivery obligations under UCC § 2-104 |
| Material Transfer Agreement (MTA) | Scope of Work Clause | To define what substance is being transferred and its permissible use |
| Employment Contract | Compensation Terms | To specify the drug provided as benefit or necessary for job performance |
| Settlement Release | Consideration Section | To identify the exact pharmaceutical or controlled substance being exchanged for release from liability |
| Regulatory Compliance Addendum | Substance List Appendix | To align commercial delivery with FDA/DEA requirements |
| Indemnification Clause | Scope of Indemnity Language | To limit liability if a specific drug causes harm to a third party |
Contract language
| Contract wording | Plain-English meaning | What to check |
|---|---|---|
| Controlled substance(s) as defined in 21 U.S.C. § 813 | Any federally regulated psychoactive or chemical agent | Ensure the correct DEA schedule (I-V) is referenced |
| Pharmaceutical compound/product | A manufactured, identifiable drug entity | Confirm if it's a finished product or an active ingredient |
| Active Agent(s) | The specific chemical that performs the therapeutic action | Verify this aligns with the FDA listing for approval purposes |
Red flags
Wording examples
Vague wording
"Drugs"
Clearer wording
"Specific FDA‑approved pharmaceutical products listed in Schedule I‑V"
Vague wording
"Compliant"
Clearer wording
"In full compliance with 21 U.S.C. § 802 and 21 CFR parts applicable to the listed substances"
Note: “clearer” means easier to read — not legally reviewed or guaranteed safe.
Pre-signature checklist
Confirm the exact generic name and DEA schedule of each drug
Verify the seller’s current DEA registration number
Ensure the contract cites the correct FDA approval letters
Check for required record‑keeping and reporting provisions
Confirm storage and transportation standards meet 21 CFR
Identify who bears liability for regulatory violations
Look for substitution clauses and define limits
Party impact
| Party | What this party should check |
|---|---|
| Seller/Supplier | Must ensure the drug meets all specified regulatory standards upon delivery. |
| Buyer/Client | Needs to confirm the drug's classification matches their intended use and legal jurisdiction requirements. |
| Manufacturer | Must verify that its production process aligns with the defined drug specifications for contractual compliance. |
| Regulated Party (e.g., Hospital) | Should check if the definition covers necessary ancillary agents needed for administration. |
Comparison
| Related term | Plain meaning | Main difference from drug |
|---|---|---|
| Controlled substance | A drug specifically listed in the Controlled Substances Act | Focuses on schedule and prohibition level |
| Pharmaceutical product | Any drug product, regulated by FDA | May include over‑the‑counter items not scheduled |
| Illicit drug | A substance prohibited by law | Differs by lack of any legal licensing pathway |
Missing or vague
If the contract simply says 'the drug,' you risk arguments over whether that means the pure chemical powder or the finished pill. Vague language might also leave open the question of *which* regulatory body governs it—FDA versus DEA, for instance. This ambiguity can stall payment if a dispute arises about whether the substance is merely an ingredient or a fully approved pharmaceutical product.
Document map
| Contract section | What to inspect |
|---|---|
| Definitions | Inspect this section first to see if 'Drug' has a cross-reference to 21 U.S.C. § 312. |
| Scope of Work | Check here to confirm the drug is meant for research, clinical trial, or commercial sale. |
| Warranties & Representations | Look for language guaranteeing the drug meets specific FDA approval criteria (e.g., NDA filing). |
| Quality Assurance/QC Clause | This specifies how purity and identity are verified against a defined standard of 'drug' quality. |
Visual model
Franchisor requires a specific proprietary drug (Formula X) for use; borrower agrees to deliver it as collateral; outcome is default if Formula X degrades.
Document context
This term functions as a classification under statutory right and contract clause type, governing the nature of goods being exchanged or regulated by government mandates.
Misidentifying the drug can cause a breach of contract claim, voiding the agreement entirely if the substance is fundamentally different from what was described. The seller bears the primary risk regarding accurate description.
The term becomes critical when performance triggers occur, such as when delivery occurs or within 30 days of the purchase order issuance under UCC § 2-601.
This concept appears frequently in Bills of Lading, standard clauses within Purchase Orders, and specific regulations found in Title 21 of the Code of Federal Regulations (CFR).
The manufacturer risks liability if a drug is mislabeled; the buyer gains rights to reject goods if the wrong substance arrives; the DEA dictates compliance for distributors.
First, the seller identifies the chemical composition and regulatory schedule of the drug. Then, the contract specifies the quantity or purity level required. Finally, acceptance hinges on verifying that the delivered item matches this defined standard.
Wikipedia
A drug is any chemical substance other than a nutrient or an essential dietary ingredient, which, when administered to a living organism, produces a biological effect. Consumption of drugs can be via inhalation, injection, smoking, ingestion, absorption via a...
Open on Wikipedia →Knowledge graph
This layer links the term to nearby glossary entries, document use cases, and contract-risk guides so readers can move from definition to context without dead ends.
Source & disclosure
This page is an AI-assisted plain-English explanation based on LexPredict Legal Dictionary context and contract-review patterns. It is not legal advice. Meaning may vary by jurisdiction, industry, and exact clause wording.
Move from term to document
A glossary definition helps, but actual risk usually lives in the surrounding clause. Upload the full document and BrieflyGo will map plain-English meaning, red flags, and next steps.
Irish Form 17.11 Information For Application To Extend Detention - Criminal Justice (Drug Trafficking) Act 1996, Section 2(2)(G) / 2(2)(H) As Amended By Criminal Justice Act 2006 - 17.11 Information For Application To Extend Detention - Criminal Justice (Drug Trafficking) Act 1996, Section 2(2)(G) / 2(2)(H) As Amended By Criminal Justice Act 2006
Irish COURTS form 17.11 Information For Application To Extend Detention - Criminal Justice (Drug Trafficking) Act 1996, Section 2(2)(G) / 2(2)(H) As Amended By Criminal Justice Act 2006: Schedule: B - Forms in criminal proceedings.
View →Irish Form 17.12 Warrant To Extend Detention - Criminal Justice (Drug Trafficking) Act 1996, Section 2(2)(G) / 2(2)(H) - 17.12 Warrant To Extend Detention - Criminal Justice (Drug Trafficking) Act 1996, Section 2(2)(G) / 2(2)(H)
Irish COURTS form 17.12 Warrant To Extend Detention - Criminal Justice (Drug Trafficking) Act 1996, Section 2(2)(G) / 2(2)(H): Schedule: B - Forms in criminal proceedings.
View →Irish Form 17.12B Warrant To Arrest - Criminal Justice (Drug Trafficking) Act 1996, Section 4(1) (As Substituted By The Criminal Justice (Amendment) Act 2009, Section 22) - 17.12B Warrant To Arrest - Criminal Justice (Drug Trafficking) Act 1996, Section 4(1) (As Substituted By The Criminal Justice (Amendment) Act 2009, Section 22)
Irish COURTS form 17.12B Warrant To Arrest - Criminal Justice (Drug Trafficking) Act 1996, Section 4(1) (As Substituted By The Criminal Justice (Amendment) Act 2009, Section 22): Schedule: B - Forms in criminal proceedings.
View →Irish Form 17.12A Information - Criminal Justice (Drug Trafficking) Act 1996, Section 4(1) (As Substituted By The Criminal Justice (Amendment) Act 2009, Section 22) - 17.12A Information - Criminal Justice (Drug Trafficking) Act 1996, Section 4(1) (As Substituted By The Criminal Justice (Amendment) Act 2009, Section 22)
Irish COURTS form 17.12A Information - Criminal Justice (Drug Trafficking) Act 1996, Section 4(1) (As Substituted By The Criminal Justice (Amendment) Act 2009, Section 22): Schedule: B - Forms in criminal proceedings.
View →BrieflyGo reviews your contracts in plain English — instantly.